Sentinel node biopsy in the staging of breast cancer

American Journal of Surgery

Volumn 176, Issue 4, 1998, Pages 305-310

  Snider, Howard ^a   Dowlatshahi, Kambiz ^b   Fan, Ming ^b   Bridger, William M ^a   Rayudu, G ^c   Oleske, Denise ^c  

^a Baptist Medical Center   (United States)

^b MF) Rush Presbyt St Luke's M ^*  (United States)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TECHNETIUM SULFUR COLLOID TC 99M;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER LOCALIZATION; CANCER STAGING; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE BIOPSY; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; PREDICTION; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; AXILLA; BIOPSY; BREAST NEOPLASMS; FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODE EXCISION; LYMPH NODES; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; TECHNETIUM TC 99M SULFUR COLLOID;

EID: 0345596477     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9610(98)00207-4     Document Type: Article

References (29)

1. Fisher B., Redmond C., Fisher E.R., et al. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with and without radiation. NEJM. 312:1985;674-681.
2. Haffty B.G., McKhann C., Beinfield M., et al. Breast conservation therapy without axillary dissection a rational treatment strategy in selected patients . Arch Surg. 128:1993;1315-1319.
3. Dent D.M. Axillary lymphadenectomy for breast cancer paradigm shifts and pragmatic surgeons . Arch Surg. 131:1996;1125-1127.
4. Silverstein M.J., Gierson E.D., Waisman J.R., et al. Axillary lymph node dissection for T1a breast carcinoma is it indicated? Cancer. 73:1994;864-867.
5. Cady B. The need to reexamine axillary lymph node dissection in invasive breast cancer. Cancer. 73:1994;505-508.
6. Cady B. Is axillary lymph node dissection necessary in routine management of breast cancer? No. Breast J. 3:1997;246-260.
7. Giuliano A.E., Kirgan D.M., Guenther J.M., Morton D.L. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg. 220:1994;391-401.
8. Giuliano A.E., Jones R.C., Brennan M., Statman R. Sentinel lymphadenectomy in breast cancer. J Clin Oncol. 15:1997;2345-2350.
9. Ollila D.W., Giuliano A.E. Intraoperative lymphatic mapping and sentinel lymphadenectomy using isosulfan blue dye. Breast Dis. 8:1998;292-300.
10. Albertini J.J., Lyman G.H., Cox C., et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA. 276:1996;1818-1822.
11. Krag D.N., Weaver D.L., Alex J.C., Fairbank J.T. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol. 2:1993;335-340.
12. Taylor A., Murray D., Herda S., et al. Dynamic lymphoscintigraphy to identify the sentinel and satellite nodes. Clin Nucl Med. 21:1996;755-758.
13. Veronesi U., Paganelli G., Galimberti V., et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet. 349:1997;1864-1867.
14. Pijpers R., Meijer S., Hoekstra O.S., et al. Impact of lymphoscintigraphy on sentinel node identification with technetium-99m-colloidal albumin in breast cancer. J Nucl Med. 38:1997;366-368.
15. Nathanson S.D., Anaya P., Karvelis K.C., et al. Sentinel lymph node uptake of two different technetium-labeled radiocolloids. Ann Surg Oncol. 4:1997;104-110.
16. Alazraki N.P., Eshima D., Eshima L.A., et al. Lymphoscintigraphy, the sentinel node concept, and the intraoperative gamma probe in melanoma, breast cancer, and other potential cancers. Sem Nucl Med. 27:1997;55-67.
17. Gulec S.A., Moffat F.L., Carroll R.G., Krag D.N. Gamma probe guided sentinel node biopsy in breast cancer. Quart J Nucl Med. 4:1997;104-110.
18. Dowlatshahi K., Fan M., Snider H.C., Habib F.A. Lymph node micrometastases from breast carcinoma reviewing the dilemma . Cancer. 80:1997;1188-1197.
19. Wilkinson E.J., Hause L., Hoffman R.G., et al. Occult axillary lymph node metastases in invasive breast carcinoma characteristics of the primary tumor and significance of the metastases . Pathol Annu. 17:(pt 2):1982;67-91.
20. Trojani M., de Mascarel I., Bonichon F., et al. Micrometastases to axillary lymph nodes from carcinoma of the breast. Br J Cancer. 55:1987;303-306.
21. Friedman S., Bertin F., Mouriesse H., et al. Importance of tumor cells in axillary node sinus margins (clandestine metastases) discovered by serial sectioning in operable breast cancer. Acta Oncol. 27:1988;483-487.
22. Prognostic importance of occult axillary lymph node micrometastases from breast cancer. Lancet. 335:1990;1565-1568.
23. de Mascarel I., Binichon F., Coindre J.M., et al. Prognostic significance of breast cancer axillary node micrometastases assessed by two special techniques re-evaluation with longer follow-up . Br J Cancer. 66:1992;523-527.
24. Clayton F., Hopkins C.I. Pathologic correlates of prognosis in lymph node positive breast carcinomas. Cancer. 71:1993;1780-1790.
25. Hainsworth P.J., Tjandra J., Stillwell R.G., et al. Detection and significance of occult metastases in node-negative breast cancer. Br J Surg. 80:1993;459-463.
26. Nasser I.A., Lee A., Bosari S., et al. Occult axillary lymph node metastases in "node-negative" breast carcinoma. Hum Pathol. 24:1993;950-957.
27. McGuckin M.A., Cummings M.C., Walsh M.D., et al. Occult axillary node metastases in breast cancer their detection and prognostic significance . Br J Cancer. 73:1996;88-95.
28. Giuliano A.E., Dale P.S., Turner R.R., et al. Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg. 222:1995;394-401.
29. Turner R.R., Ollila D.W., Drasne D.L., et al. Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma. Ann Surg. 226:1997;271-278.